Delivery Order SPE2DB20D1100-SPE2DB24FD3H5

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Pitavastatin 2 mg tablets. The $1,996.37 firm fixed-price delivery order contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,204.62, is a Delivery Order for the supply of 4566816334 - Pitavastatin 1 mg Tablet, 90s. The contract has a firm fixed price pricing type and an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This federal contract award, valued at $1,829.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567039797 pitavastatin 2 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $2,977.16 and a completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIVALO 2 MG TABLET 90S. The contract has a ceiling value of $1,273.59 and runs through August 6, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order (SPE2DB24FN7V7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,571,363 units of Atorvastatin 40 mg tablets. The contract has a ceiling value of $1,140.61 and a completion date of May 13, 2024. It is a Firm Fixed Price contract with no set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.38 Firm Fixed Price delivery order is for 4,567,490,649 units of 10 mg Atorvastatin tablets. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Simvastatin 10 mg tablets. The contract has a ceiling value of $2,179.14 and runs through December 10, 2024. It is a firm-fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of LIVALO 4 MG TABLET 90S. The contract has a ceiling value of $4,478.00 and a period of performance through February 4, 2025. It is a Firm Fixed Price contract, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,094.07 firm fixed-price delivery order is for the supply of 4,561,290 units of Atorvastatin 10 mg tablets, a cardiovascular medication, with a completion date of June 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD3H5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pitavastatin 2 mg tablets. The contract has a ceiling value of $2,186.23 and a performance period through August 20, 2024. It is a firm fixed-price delivery order contract without a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This specific delivery order is part of that broader IDC vehicle, enabling the DLA to efficiently procure these essential pharmaceutical products from Amerisourcebergen to support the healthcare needs of military personnel and other federal beneficiaries.

Generated 11/18/24, 9:44 AM